blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1810970

EP1810970 - Therapeutic piperazine compounds [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  18.03.2011
Database last updated on 21.05.2024
Most recent event   Tooltip13.09.2013Lapse of the patent in a contracting state
Updated state(s): BG		published on 16.10.2013  [2013/42]
Applicant(s)For all designated states
EURO-CELTIQUE S.A.
2, avenue Charles de Gaulle
1653 Luxembourg / LU
[2008/23]
Former [2007/30]For all designated states
EURO-CELTIQUE S.A.
122 Boulevard de la Petrusse
2330 Luxembourg / LU
Inventor(s)01 / Sun, Qun
19 Aldgate Court
Princeton, NJ 08540 / US
02 / Zhou, Xiaoming
22 Dogwood Drive
Plainsboro, NJ 08536 / US
 [2007/30]
Representative(s)Hansen, Norbert
Maiwald GmbH
Elisenhof
Elisenstraße 3
80335 München / DE
[N/P]
Former [2007/30]Hansen, Norbert
Maiwald Patentanwalts GmbH Elisenhof Elisenstraße 3
80335 München / DE
Application number, filing date07104074.524.09.2003
[2007/30]
Priority number, dateUS20020412847P24.09.2002         Original published format: US 412847 P
[2007/30]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP1810970
Date:25.07.2007
Language:EN
[2007/30]
Type: B1 Patent specification 
No.:EP1810970
Date:12.05.2010
Language:EN
[2010/19]
Type: B8 Corrected title page of specification 
No.:EP1810970
Date:26.01.2011
[2011/04]
Type: B8 Corrected title page of specification 
No.:EP1810970
Date:26.01.2011
[2012/12]
Type: B8 Corrected title page of specification 
No.:EP1810970
Date:21.03.2012
[2012/12]
Search report(s)(Supplementary) European search report - dispatched on:EP05.06.2007
ClassificationIPC:C07D403/04, C07D401/04, C07D285/10, C07D237/20, C07D241/20, C07D239/42, C07D213/74, A61K31/496, A61P29/00
[2007/30]
CPC:
C07D401/04 (EP,KR,US); A61P1/04 (EP); A61P1/08 (EP);
A61P1/14 (EP); A61P13/10 (EP); A61P17/04 (EP);
A61P19/02 (EP); A61P21/02 (EP); A61P25/00 (EP);
A61P25/02 (EP); A61P25/04 (EP); A61P25/06 (EP);
A61P25/08 (EP); A61P25/14 (EP); A61P25/16 (EP);
A61P25/18 (EP); A61P25/22 (EP); A61P25/24 (EP);
A61P25/28 (EP); A61P25/32 (EP); A61P25/34 (EP);
A61P25/36 (EP); A61P27/02 (EP); A61P29/00 (EP);
A61P29/02 (EP); A61P3/04 (EP); A61P39/02 (EP);
A61P43/00 (EP); A61P9/00 (EP); C07D241/20 (KR);
C07D403/04 (EP,US); C07D417/04 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   RO,   SE,   SI,   SK,   TR [2007/30]
Extension statesAL13.03.2007
LV13.03.2007
MK13.03.2007
TitleGerman:Therapeutische Piperazinverbindungen[2007/30]
English:Therapeutic piperazine compounds[2007/30]
French:Composés thérapeutiques de pipérazine[2007/30]
Examination procedure13.03.2007Examination requested  [2007/30]
18.10.2007Despatch of a communication from the examining division (Time limit: M06)
16.04.2008Reply to a communication from the examining division
08.10.2009Communication of intention to grant the patent
12.02.2010Fee for grant paid
12.02.2010Fee for publishing/printing paid
Parent application(s)   TooltipEP03754883.1  / EP1562936
Opposition(s)15.02.2011No opposition filed within time limit [2011/16]
Fees paidRenewal fee
13.03.2007Renewal fee patent year 03
13.03.2007Renewal fee patent year 04
21.09.2007Renewal fee patent year 05
23.10.2008Renewal fee patent year 06
04.09.2009Renewal fee patent year 07
Penalty fee
Additional fee for renewal fee
30.09.200806   M06   Fee paid on   23.10.2008
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT12.05.2010
BE12.05.2010
CY12.05.2010
CZ12.05.2010
DK12.05.2010
EE12.05.2010
FI12.05.2010
IT12.05.2010
NL12.05.2010
PT12.05.2010
RO12.05.2010
SE12.05.2010
SI12.05.2010
SK12.05.2010
TR12.05.2010
BG12.08.2010
GR13.08.2010
ES23.08.2010
HU13.11.2010
[2013/42]
Former [2013/32]AT12.05.2010
BE12.05.2010
BG12.05.2010
CY12.05.2010
CZ12.05.2010
DK12.05.2010
EE12.05.2010
FI12.05.2010
IT12.05.2010
NL12.05.2010
PT12.05.2010
RO12.05.2010
SE12.05.2010
SI12.05.2010
SK12.05.2010
TR12.05.2010
GR13.08.2010
ES23.08.2010
HU13.11.2010
Former [2012/47]AT12.05.2010
BE12.05.2010
BG12.05.2010
CY12.05.2010
CZ12.05.2010
DK12.05.2010
EE12.05.2010
FI12.05.2010
IT12.05.2010
NL12.05.2010
RO12.05.2010
SE12.05.2010
SI12.05.2010
SK12.05.2010
TR12.05.2010
GR13.08.2010
ES23.08.2010
HU13.11.2010
Former [2012/42]AT12.05.2010
BE12.05.2010
BG12.05.2010
CY12.05.2010
CZ12.05.2010
DK12.05.2010
EE12.05.2010
FI12.05.2010
IT12.05.2010
NL12.05.2010
RO12.05.2010
SE12.05.2010
SI12.05.2010
SK12.05.2010
GR13.08.2010
ES23.08.2010
HU13.11.2010
Former [2012/41]AT12.05.2010
BE12.05.2010
BG12.05.2010
CY12.05.2010
CZ12.05.2010
DK12.05.2010
EE12.05.2010
FI12.05.2010
IT12.05.2010
NL12.05.2010
RO12.05.2010
SE12.05.2010
SI12.05.2010
SK12.05.2010
GR13.08.2010
ES23.08.2010
Former [2011/20]AT12.05.2010
BE12.05.2010
CY12.05.2010
CZ12.05.2010
DK12.05.2010
EE12.05.2010
FI12.05.2010
IT12.05.2010
NL12.05.2010
RO12.05.2010
SE12.05.2010
SI12.05.2010
SK12.05.2010
GR13.08.2010
ES23.08.2010
Former [2011/06]AT12.05.2010
CY12.05.2010
FI12.05.2010
NL12.05.2010
SE12.05.2010
SI12.05.2010
GR13.08.2010
ES23.08.2010
Former [2010/45]NL12.05.2010
Documents cited:Search[A]WO0052001  (SAMJIN PHARM CO LTD [KR], et al) [A] 1-61* abstract *;
 [X]WO0208221  (NEUROGEN CORP [US], et al) [X] 1-61 * claims; page 1 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.